Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.

Zuxiong HuangNing WangShuiwen HuangYi ChenShida YangQiaorong GanHanhui Ye Baorong Liu Chen Pan

Published in: Gastroenterology research and practice (2019)

Serum suPAR level increases significantly in HB-ACLF patients and associated with a 90-day mortality. It suggests that suPAR might be a potential biomarker to predict the prognosis of HB-ACLF patients.

Keyphrases

liver failure
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
type diabetes
cardiovascular disease
cardiovascular events
drug induced